Drug Safety Newsletter Issue 63
Download:
drug-safety-newsletter-issue-63.pdf
1 MB
In this Edition
- Health Products Regulatory Authority (HPRA)
- Transdermal fentanyl: Reminder about the potential for life-threatening harm from accidental exposure to transdermal fentanyl
- Denosumab (Prolia): Updated information to minimise the risk of osteonecrosis of the jaw and hypocalcaemia.
- Ferumoxytol (Rienso): New important advice to mitigate the risk of serious hypersensitivity reactions.
- Beta interferons: Risk of thrombotic microangiopathy and nephrotic syndrome
- Adverse Reaction Reporting during 2013
- Direct Healthcare Professional Communications published on the HPRA website since the last Drug Safety Newsletter
« Back